Inactive Instrument

News PHAXIAM Therapeutics S.A. Nasdaq

Equities

ERYP

US29604W2070

Summary

Unlock all the news: Be the first to know and act before the market!

PHAXIAM announces the availability of the preparatory documents for the Combined General Meeting of 28 June 2024	07/06	GL
PHAXIAM provides Business and Financial Update for the First Quarter of 2024	15/05	GL
Phaxiam initiates trial in infective endocarditis	15/04	CF
PHAXIAM Therapeutics announces enrolment of the first patient in the phase 1 study for the treatment of endocarditis infections caused by Staphylococcus aureus	15/04	GL
PHAXIAM Therapeutics Announces Enrolment of First Patient in the Phase 1 Study for the Treatment of Endocarditis Infections Caused by Staphylococcus Aureus	15/04	CI
PHAXIAM Therapeutics announces filing of its 2023 Universal Registration Document (URD)	05/04	GL
Transcript : PHAXIAM Therapeutics S.A., Q4 2023 Earnings Call, Mar 21, 2024	21/03
PHAXIAM Announces 2023 Full-Year Results and Provides Business Update	20/03	GL
PHAXIAM Therapeutics S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	20/03	CI
PHAXIAM Therapeutics Completes Delisting of ADS From Nasdaq	11/03	MT
Phaxiam Therapeutics Delists from Nasdaq Capital Market	11/03	MT
PHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock Market	11/03	GL
PHAXIAM Therapeutics S.A.(NasdaqCM:PHXM) dropped from NASDAQ Composite Index	08/03	CI
ADRs Slump, Quoin Pharmaceuticals Ltd. Declines 48.3%	06/03	DJ
ADRs Slump; Jianpu Technology Declines 62%	22/02	DJ
Global markets live: BAE Systems, HSBC, Nvidia, Tesla, Boeing...	21/02
Phaxiam to delist ADS from Nasdaq in March	21/02	CF
PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital Market	21/02	GL
PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital Market	21/02	AQ
PHAXIAM Therapeutics S.A.(NasdaqCM:PHXM) added to NASDAQ Composite Index	30/23/30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News PHAXIAM Therapeutics S.A. Nasdaq

Equities

ERYP

US29604W2070

Summary

Filters